Wei Tong, Ph.D.

Wei Tong, Ph.D.

Assistant Professor of Pediatrics

Department of Pediatrics

The Children’s Hospital of Philadelphia
316A Abramson Research Center
3615 Civic Center Blvd.
Philadelphia, PA 19104


This email address is being protected from spambots. You need JavaScript enabled to view it.


Hundreds of billions of blood cells have to be replenished everyday. Cytokines and cytokine receptors play important roles in blood cell formation, a process known as hematopoiesis. The amplitude and duration of cytokine receptor signaling is a highly regulated process that is crucial for cytokine-governed hematopoiesis. Dysregulation of these complex signaling networks can predispose to myeloproliferative diseases and myeloid leukemia.

We previously identified the adaptor protein, Lnk, as a novel negative regulator of cytokine receptor signaling. Lnk deficiency in mice results in an enhanced proliferative capacity of hematopoietic stem cells (HSCs) and progenitor cells of multiple lineages. Lnk loss-of-function leads to hyper-sensitivity to thrombopoietin (Tpo) and erythropoietin (Epo), which regulate platelet and red blood cell formation, respectively. Our results also implicate a new mechanism for rapidly downmodulating cytokine signaling: Lnk negatively regulates cytokine receptor induced JAK2 activity in a phosphorylation-dependent manner. We are interested in:

  • Elucidating molecular mechanisms of Lnk regulatory functions in cytokine receptor signaling.
  • Understanding both normal and oncogenic cytokine receptor signaling processes that control hematopoietic stem and progenitor cell numbers and development in vivo
  • Undertaking studies to identify novel signaling components in the receptor/JAK2. signaling complex that lead to oncogenic transformation, as JAK2 is the central kinase governing many cytokine receptor signaling, and has been found mutated in some patients with myeloproliferative disease.